Initial experience with fenoldopam in children

American Journal of Therapeutics
L M StrauserJ D Tobias

Abstract

Fenoldopam is a direct-acting vasodilator that acts at the postsynaptic dopamine 1 receptors in renal, coronary, cerebral, and splanchnic vasculature resulting in arterial dilation and a lowering of the mean arterial pressure (MAP). Preliminary evidence suggests its efficacy in the treatment of hypertensive urgencies and emergencies in adults. We present four children in whom fenoldopam was used to control MAP in various clinical scenarios, including hypertensive emergencies and urgencies, intraoperative reduction of MAP for controlled hypotension, and control of MAP during extracorporeal membrane oxygenation. The possible applications of fenoldopam and suggested dosing regimens in children are reviewed.

Citations

May 1, 2002·Current Opinion in Pediatrics·Umbereen S Nehal, Julie R Ingelfinger
Nov 15, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Chad A KnodererSharon P Andreoli
Nov 5, 2003·Current Hypertension Reports·William J Elliott
Mar 12, 2011·International Journal of Clinical Pharmacy·D G HornG Hempel
Sep 11, 2008·Interactive Cardiovascular and Thoracic Surgery·Zaccaria RicciSergio Picardo
Nov 3, 2010·Best Practice & Research. Clinical Anaesthesiology·Joseph R Tobin
Sep 26, 2003·Current Opinion in Pediatrics·Chitra RavishankarGil Wernovsky
Nov 28, 2013·Pharmaceuticals·Joseph D TobiasSergio D Bergese
Mar 23, 2002·International Anesthesiology Clinics·Elamana Vijayakumar
Sep 29, 2006·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Brady S Moffett, Renán Orellana
Apr 1, 2005·Current Opinion in Pediatrics·Hiren P Patel, Mark Mitsnefes
May 23, 2008·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Brady S MoffettJohn Lynn Jefferies
Jun 9, 2005·Pediatric Emergency Care·Erika Constantine, James Linakis
Jan 6, 2006·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·John M CostelloPeter C Laussen
Sep 12, 2020·Pediatric Cardiology·Joseph D TobiasCatherine D Krawczeski
Jan 29, 2005·Paediatric Anaesthesia·Todd SmithJoseph D Tobias
May 19, 2021·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Gianluigi ArdissinoUNKNOWN ItalKid-HUS Network

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.